相关实验视频
Updated: Jan 17, 2026

08:51
Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
5.3K
在零星晚发的小脑动症的进展和挑战
Thomas Wirth1,2,3, Jennifer Faber4,5, Christel Depienne6
1Department of Neurology, University Hospital of Strasbourg, Strasbourg, France.
Nature reviews. Neurology
|September 22, 2025
概括
随机晚发大脑动症 (SLOCA) 诊断正在改进,新的标准和生物标志物识别了已知的原因. 基因测试揭示了新的分子起源,如FGF14和RFC1基因扩张,进步了SLOCA的理解.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 零星晚期发作的小脑缩症 (SLOCA) 是40岁后没有家族病史的渐进性缩症的特征.
- 相关疾病的诊断标准和生物标志物发展的最新进展有助于SLOCA诊断.
- 不断发展的DNA测序技术正在揭示SLOCA的新型遗传基础.
研究的目的:
- 提出一种最新的临床方法来诊断和管理SLOCA.
- 要突出最近在了解SLOCA的原因和管理方面的关键发展.
- 讨论SLOCA研究和治疗的未来方向.
主要方法:
- 对SLOCA的当前文献和诊断框架的审查.
- 对新发现的遗传原因进行分析,包括FGF14和RFC1基因扩展.
- 讨论诊断技术的进步,如DNA测序.
主要成果:
- 修订的多系统缩诊断标准和新的生物标志物有助于识别获得的SLOCA原因.
- 发现了遗传性疾病,如脊髓缩型27B型 (FGF14基因) 和CANVAS (RFC1基因) 作为SLOCA的原因.
- 由于技术进步,增加了诊断SLOCA的能力.
结论:
- 对于SLOCA的诊断环境有了显著的改善,使得能够更好地识别各种原因.
- 持续的研究对于发现剩余的遗传原因和开发有效的治疗方法至关重要.
- 未来的努力应集中在SLOCA中神经保护干预的预后和临床试验上.
相关概念视频
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

